Palatin Technologies
PTN
#10358
Rank
S$27.13 M
Marketcap
S$15.25
Share price
0.00%
Change (1 day)
13,072.17%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -S$6.57 Million

According to Palatin Technologies's latest financial reports the company's current earnings are S$8.84 Million. In 2024 the company made an earning of -S$34.61 Million, an increase over its 2023 earnings that were of -S$41.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$6.57 Million-81.02%
2024 -S$34.61 Million-16.9%
2023 -S$41.65 Million5.99%
2022 -S$39.3 Million-13.7%
2021 -S$45.53 Million33.25%
2020 -S$34.17 Million-172.11%
2019 S$47.38 M2352.33%
2018 S$1.93 M-94.13%
2017 S$32.92 M-154.92%
2016 -S$59.95 Million3.67%
2015 -S$57.83 Million878%
2014 -S$5.92 Million-72.64%
2013 -S$21.61 Million-33.11%
2012 -S$32.31 Million77.71%
2011 -S$18.18 Million
2003 -S$30.79 Million29.93%
2002 -S$23.7 Million36.18%
2001 -S$17.4 Million
1999 -S$14.44 Million6.04%
1998 -S$13.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.37 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.83 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.02 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$15.43 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.21 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$0.12 B-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-S$37.88 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$74.44 Million 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA